Mesoblast reported -45727000 in Operating Profit for its fiscal semester ending in June of 2024.


Operating Profit Change Date
Avita Medical AUD -9957000 5.64M Dec/2024
Clinuvel Pharmaceuticals AUD 39.05M 21.49M Jun/2024
Cochlear AUD 274.6M 54.5M Dec/2024
CSL USD 1.98B 778M Dec/2024
Pacific Edge NZD -15314000 7.45M Sep/2024
Paradigm Biopharmaceuticals AUD -5930700 3.79M Dec/2024
PYC Therapeutics AUD -25891160 14.18M Dec/2024
Ramsay Health Care AUD 200M 285.4M Dec/2024
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Starpharma Holdings AUD -5392000 1.82M Dec/2024
Telix Pharmaceuticals AUD 17.72M 24.27M Dec/2024